Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.

MagicTouch PTA -Sirolimus Coated Balloon has recently received IDE approval from the US FDA for SFA indication

News | Drug-Eluting Balloons

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

May 30, 2023 — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Conce ...

May 30, 2023

Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD) were presented during the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions, held May 18-20 in Phoenix, AZ. Results found marijuana users are at a significantly increased risk of developing PAD, compared to the general population.

News | SCAI

Marijuana Users Three Times More Likely to Develop Peripheral Artery Disease

May 19, 2023 — Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD ...

May 19, 2023

Along with this latest IDE approval for the treatment of Small Vessel indication, Concept Medical received two other IDE approvals for the Magic Touch SCB family of products for the treatment of coronary In-Stent Restenosis (ISR) indication and Below-the-Knee indication (PTA)

News | Drug-Eluting Balloons

Concept Medical's Receives FDA Approval for the MagicTouch-Sirolimus Coated Balloon

May 12, 2023 — The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel ...

May 12, 2023

FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the issuance of its second utility patent by the USPTO. This milestone showcases FastWave Medical's unparalleled efficiency in developing novel intravascular lithotripsy (IVL) systems to address the $9 billion market.

News | Embolic Protection Devices

FastWave Medical Granted Second Utility Patent to Advance the Future of Cardiovascular Calcium Treatment

April 25, 2023 — FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the ...

April 25, 2023

Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in women, according to a review published today in European Heart Journal – Quality of Care and Clinical Outcomes, a journal of the European Society of Cardiology (ESC)

News | Peripheral Artery Disease (PAD)

Clogged Leg Arteries Underdiagnosed and Undertreated in Women

March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...

March 08, 2023

Salim Virani, MD, PhD, staff cardiologist at the Michael E. DeBakey VA Medical Center in Houston, vice provost for research and professor at the Aga Khan University in Karachi, Pakistan, and staff at The Texas Heart Institute/Baylor College of Medicine.

News | Peripheral Artery Disease (PAD)

Targeted Reminders Increase Prescriptions for High-Intensity Statins

March 5, 2023 — Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were ...

March 05, 2023

Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA 510(k) clearance for reprocessing the Philips IVUS Eagle Eye Platinum RX Digital catheter.

News | Intra-Vascular Ultrasound (IVUS)

Northeast Scientific Inc. awarded 510(k) clearance to reprocess the Eagle Eye Platinum RX Digital IVUS Catheter

February 16, 2023 — Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters ...

February 16, 2023

$Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market$

News | Cardiovascular Business

Shockwave Medical Announces Agreement to Acquire Neovasc

January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...

January 19, 2023

News | Embolic Protection Devices

Shockwave Intravascular Lithotripsy-assisted TMVR Shows Promise for Patients with Severe Stenosis and Regurgitation

January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved ...

January 11, 2023

News | Peripheral Artery Disease (PAD)

Modern Vascular and Local Interventional Radiologist Pair Up To Reduce Unnecessary Amputations in Houston, Texas

December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease ...

December 29, 2022

According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be valued at $2,897.2 million in 2022 and is expected to exhibit a CAGR of 6.6 % during the forecast period (2022-2030).

News | Stents Drug Eluting

Global Drug Eluting Stents Market to Surpass US$ 4,844.6 Million by 2030, Says Coherent Market Insights

December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...

December 23, 2022

Certain adults with this artery-blocking condition may see more benefits with an open bypass compared to less-invasive procedures to improve circulation.

News | Peripheral Artery Disease (PAD)

Bypass Surgery Favorable for Initial Treatment of Chronic Limb-Threatening Ischemia

November 15, 2022 Performing open bypass surgery to restore circulation for people with a severe form of peripheral ...

November 15, 2022

Edwin A. Takahashi, M.D., assistant professor of radiology in the division of interventional radiology at the Mayo Clinic College of Medicine in Rochester, Minnesota. Copyright Mayo Clinic College of Medicine

News | AHA

Telehealth is a Valuable Option in Cardiovascular Care, Though Challenges Remain

November 15, 2022 — Telehealth is a proven and valuable option for people with cardiovascular disease, however, there ...

November 15, 2022

Grant Proceeds Will Support Pre-Clinical Studies

News | Stents Bioresorbable

Efemoral Medical Awarded Phase II SBIR Grant from NIH to Advance Treatment for Peripheral Artery Disease

October 11, 2022 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it ...

October 11, 2022

The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon.

News | Drug-Eluting Balloons

First US Patient Enrolled in SELUTION SLR IDE Peripheral Study

August 23, 2022 — The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial ...

August 23, 2022